Mangrove Partners’s CERo Therapeutics Warrants CEROW Stock Holding History

Mangrove Partners’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-163,538	Closed	-$1.78M	–	175
2023 Q2	$1.78M	Hold	163,538	–	–	0.12%	143
2023 Q1	$1.75M	Hold	163,538	–	–	0.11%	166
2022 Q4	$1.68M	Hold	163,538	–	–	0.09%	227
2022 Q3	$1.65M	Hold	163,538	–	–	0.1%	243
2022 Q2	$1.64M	Hold	163,538	–	–	0.08%	346
2022 Q1	$1.64M	Hold	163,538	–	–	0.1%	329
2021 Q4	$1.62M	Buy	+163,538	New	+$75.4K	0.1%	384

Other funds holding CEROW

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return

Segantii Capital Management Hong Kong $1.02B AUM 16.73% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.39B AUM 64.83% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return